Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Judy Lieberman, M.D., Ph.D.

Co-Author

This page shows the publications co-authored by Judy Lieberman and Winston Hide.
Connection Strength

0.767
  1. Immunotherapy for breast cancer using EpCAM aptamer tumor-targeted gene knockdown. Proc Natl Acad Sci U S A. 2021 03 02; 118(9).
    View in: PubMed
    Score: 0.239
  2. Sequencing of captive target transcripts identifies the network of regulated genes and functions of primate-specific miR-522. Cell Rep. 2014 Aug 21; 8(4):1225-39.
    View in: PubMed
    Score: 0.152
  3. A genome-wide siRNA screen identifies proteasome addiction as a vulnerability of basal-like triple-negative breast cancer cells. Cancer Cell. 2013 Aug 12; 24(2):182-96.
    View in: PubMed
    Score: 0.142
  4. Capture of microRNA-bound mRNAs identifies the tumor suppressor miR-34a as a regulator of growth factor signaling. PLoS Genet. 2011 Nov; 7(11):e1002363.
    View in: PubMed
    Score: 0.126
  5. miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to "seedless" 3'UTR microRNA recognition elements. Mol Cell. 2009 Sep 11; 35(5):610-25.
    View in: PubMed
    Score: 0.108
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.